HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

2nd Edition of International Cancer Research Conference

March 19-21, 2026 | Singapore

March 19 -21, 2026 | Singapore

Cancer Neoantigens

Cancer Neoantigens

Cancer neoantigens are novel peptides presented by cancer cells that arise from tumor-specific mutations. Unlike normal cellular proteins, these neoantigens are recognized as foreign by the immune system, making them promising targets for cancer immunotherapy. Neoantigen-based therapies, such as personalized cancer vaccines and adoptive T-cell transfer, aim to harness the body’s immune response to selectively attack tumor cells while sparing healthy tissue. Recent advances in genomics and bioinformatics have accelerated the identification and validation of neoantigens, paving the way for highly individualized treatments. These therapies hold potential for improved efficacy and reduced toxicity compared to traditional cancer treatments, marking a significant advancement in personalized oncology.

Committee Members
Speaker at International Cancer Research Conference - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Research Conference - Anyou Wang

Anyou Wang

DIFIBER LLC, United States
Speaker at Oncology Conferences - Michael Thompson

Michael Thompson

University of Toronto, Canada
Cancer Research 2026 Speakers
Speaker at Cancer Research Conferences - Can Küçük

Can Küçük

Dokuz Eylul University, Turkey
Speaker at International Cancer Research Conference - Nadia Leney Olazo Marquez

Nadia Leney Olazo Marquez

Benemérita Universidad Autónoma de Puebla, Mexico
Speaker at International Cancer Research Conference - Liu Ying

Liu Ying

Shanghai University, China
Speaker at International Cancer Research Conference - Ratan Kumar Sarkar

Ratan Kumar Sarkar

Independent Researcher, India

Submit your abstract Today

Watsapp